Amid MFN talks, Lilly chief warns US adoption of international drug prices could bring worst of two worlds

Eli Lillys CEO comments on U.S. drug pricing reform amid MFN talks, highlighting issues in the healthcare system. The companys new diabetes and obesity drugs show strong sales growth.

Navigating Pharmas AI Frontier: Crafting Customer Journey Orchestration for Impact

PD-(L)1/VEGF之后，双抗BD的新王牌藏在哪？

【首发】芝诺科技完成数千万元人民币Pre-A轮融资，引领天然微生物色素与药食同源功能成分新未来

【首发】核舟医药完成数千万美元A轮融资，加速新型Alpha放射性药物的开发与产业化

生物制造“冰火两重天”：半年盈利超190亿！6家利润翻倍，9家亏损

跨国药企洞察｜从波立维降价到波立达退市，“赛诺菲”们如何转身？

Indian API maker Garonit Pharma plans $46.1M antiseptic product plant in New York

就位！医械早知道-8/7

医保政策支持创新药械，全链条保障促进医疗器械发展，涉及多方参与。

报名启动！第九届研发客临床年会暨ChinaTrials17，11月12日蓄势待发

STAT+: Exact Sciences acquires rights to rival Freenome’s blood-based colon cancer test

Scientific innovation is driving hope for progress in women’s health, but experts warn of headwinds 

Opinion: Trump deserves the Nobel Peace Prize for Operation Warp Speed’s global impact

STAT+: Sarepta hired a Trump-connected firm to lobby on Duchenne treatment

神经科学工具书——《精神疾病啮齿类动物模型及行为学实验》 崔东红/徐林著